APR 23, 2016 7:57 AM PDT

Surgeons Stimulate Torn ACLs to Self-Heal with a Sponge

WRITTEN BY: Xuan Pham
Each year, surgeons perform roughly 100,000 reconstruction procedures on torn anterior cruciate ligaments (ACLs). This knee injury is most commonly acquired during sports activities that involve rapid stopping and pivoting. ACL reconstructions are notorious for having a long healing time and a high risk for arthritis in the later years.
 
To improve patient outcome with minimal invasiveness, orthopedic surgeons at the Boston’s Children Hospital (BCH) developed a technique that uses the body’s own repair mechanisms to fix the torn ligament. The procedure is hailed as a “game-changer” in the field, as it could significantly shorten the healing time from the 6-9 months to as little as 3 months. Furthermore, the new technique eliminates the need to take tendons and ligaments from other parts of the body.
 
Dr. Martha MurrayMartha Murray, orthopedic surgeon at BCH, pioneered the procedure that’s named Bridge-Enhanced ACL Repair (BEAR). The procedure relies on a bio-enhanced sponge that’s placed in between the torn ends of ligaments, providing a so-called bridge for the ligament to grow into. The sponge is then infused with the patient’s own blood, which clots and stimulates a natural healing process. Surgeons then pull the ends of the torn ligament into the sponge, and over time, the ends heal and connect back to each other. The sponge is replaced by the healing tissue.



The inspiration for BEAR came from when Murray observed how other ligaments in the body heal itself. In particular, she found the medial collateral ligament of the knee self-healed with the help of a blood clot that joined the ends together. But because joint fluid prevents a natural clot from forming at ACL tears, she had to devise a scaffold to connect the tears.
 

As she hoped, the sponge yielded impressive results in preclinical trials. Her team then moved to a Phase 1 trial that included 20 patients with torn ACLs, 10 of whom received the BEAR procedure while the other 10 received the standard ACL reconstruction.
 
Though both groups are rehabilitating well, the BEAR-treated group notably recovered sooner, as they did not have their hamstring tendon removed for use as graft. “The safety study showed us that this is possible,” said Murray. “The ACL can regenerate and come back. We can let our body do what it does so well. We can give it a little piece of machinery like the sponge bridge, rather than taking stuff out and putting something else in like a tendon graft and forcing it to do something that’s not quite as natural. I’m hoping that the BEAR will shift how people look at ACL surgery.”
 
No one in the BEAR-treated group reported infections or knee stiffness. Additionally, if her animal trial results hold up in the patients, those treated with BEAR may have lower risks of arthritis in the repaired knee. Currently, it’s estimated that nearly 80 percent of patients with ACL tears will develop osteoarthritis within 14 years of the injury. A reduction in this risk will be another huge added benefit to the already minimally invasive BEAR procedure.
 
But experts caution that it’s still too soon to make conclusions. “It has the potential to be a game-changer, but it’s still early in the process,” said Jo Hannafin, a sports medicine surgeon at New York City’s Hospital for Special Surgery. “These patients will have to be followed for a minimum of two years to determine whether the ACL heals and does that healed ACL stay competent or stretch over time and fail.”
 
Meanwhile, Murray and her team are proceeding with Phase 2 of the trial. This time, they will enroll 100 patients for a randomized trial in which two-thirds will receive the BEAR treatment. With positive results, Murray hopes the procedure will be more widespread and available in the next three to four years.

Additional sources: Boston Globe
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JAN 14, 2021
Clinical & Molecular DX
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
JAN 14, 2021
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
  Only 10 percent of icebergs are visible on the surface of the water; the remaining 90 percent remains submerged. ...
JAN 26, 2021
Clinical & Molecular DX
Prostate Cancer Screening: No More False Positives
JAN 26, 2021
Prostate Cancer Screening: No More False Positives
A new diagnostic test powered by artificial intelligence has been found to detect prostate cancer markers in urine sampl ...
JAN 24, 2021
Genetics & Genomics
Rare Neurodevelopment Disorder LINKED is IDed
JAN 24, 2021
Rare Neurodevelopment Disorder LINKED is IDed
Scientists have now characterized a genetic disorder called linkage-specific-deubiquitylation-deficiency-induced embryon ...
JAN 26, 2021
Cell & Molecular Biology
Diagnostic Tool Could ID 20% of Autism Cases
JAN 26, 2021
Diagnostic Tool Could ID 20% of Autism Cases
Scientists may have created a diagnostic test that can identify as many as one-fifth of potential autism spectrum disord ...
JAN 26, 2021
Genetics & Genomics
Why Only Some People With a Rare Mutation Get a Heart Condition
JAN 26, 2021
Why Only Some People With a Rare Mutation Get a Heart Condition
Scientists have found a way to explain why a heart condition called hypertrophic cardiomyopathy (HCM) can be so differen ...
FEB 03, 2021
Clinical & Molecular DX
New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy
FEB 03, 2021
New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy
Rheumatoid arthritis, or RA, is a painful and debilitating autoimmune disorder of the joints, particularly those of the ...
Loading Comments...